Samrat Pharmachem Ltd. Stock price: Live updates

₹208.3

1.61% (3.3)

Market Cap

₹63 Cr.

P/E

0.00

Key Ratios

Edit Ratio's

Market cap

63.00 Cr

Prom Holding

49.09 %

ROE (%)

9.91

ROCE (%)

14.69

Div Yield (%)

Sales

289 Cr

OPM (%)

-0.74 %

Debt to Equity

0.14

Institutions

3.24 %

Individual < 2 lac

36.12 %

No. of Shareholders

6,311

Edit Ratio's

About

Samrat Pharmachem Ltd specializes in manufacturing iodine salts & bromine salts used in indust… Read more

Low

190

52W Range

High

389

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

6 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

2 No Data

Insufficient data to analyse

Accounting & Shareholding

Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Promoter Holding

Promoter has not sold any shares in the last 90 days
Depreciation Effect

Company is depreciating a lower percentage of assets. this is contributing to an increase in net profit
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales
Contingent Liabilities

Unable to calculate due to limited data

Price & Performance

ROE

Asset turnover is responsible for roe increase over last 10 years
Share price

Share price has increased over last 10 years due to earnings
Working Capital

Working capital of the company seems to be under control
Debt

Company should not have issues servicing its debt
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Capex vs ROCE

Roce of the company has decreased even without significant capex
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
Current vs Historic Valuation

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on Samrat Pharmachem Ltd. Business

What does Samrat Pharmachem do?

Who are the competitors of Samrat Pharmachem?

Is Samrat Pharmachem financially stable compared to its competitors?

View FAQ's On Shareprice

Promoter Increasing Stake

Promoters buy for just one reason - stock will go up. List of comapnies with them continuosly increasing stake

Run Query

Company Filing

	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Claude

Discussions & Analysis

Samrat Pharmachem Ltd.

View the discussion on ValuePickr

Ideas Dashboard

Results

Timeline

Watchlist

Portfolio

Alerts

Stock Screener

Market

Raw Material

Samrat Pharmachem Ltd.

Samrat Pharmachem Ltd.

Key Ratios

About

Timeline

Company Timeline

Custom financial statement

Forensics

6 Yes

2 Neutral

7 No

2 No Data

Accounting & Shareholding

Other Income

Pledge

Promoter Holding

Depreciation Effect

Retail Holding

Revenue Recognition

Contingent Liabilities

Price & Performance

ROE

Share price

Working Capital

Debt

Balance Sheet Strength

Capex vs ROCE

Sales Growth

Margin Stability

ROCE Strength

Current vs Historic Valuation

Revenue mix

Product Wise Break-Up

UNLOCK PREMIUM

Peer Comparison

Corporate Actions

FAQs on Samrat Pharmachem Ltd. Business

What does Samrat Pharmachem do?

Who are the competitors of Samrat Pharmachem?

Is Samrat Pharmachem financially stable compared to its competitors?

Similar Companies

Company Filing

Discussions & Analysis

SIGN UP FOR FREE